YI
Yimei
Retatrutide
50 tests · latest 30 Apr 2026
38%
NEA rating
#18 of 26 Retatrutide vendors
17 of 31 classifiable tests passed
natural 96% · customers 4.5★ (25)
NEA analysis · Retatrutide
Yimei Retatrutide underperforms: purity of 94.4% and fill comes in light at 92.1% of label put it below tolerance on most lots. Independent confirmation is strongly advised before use.
Purity focus — purity 99.5%+, dose ±35%methodology
Peptides
3 rated · tap to focus| # | Peptide | Rating | N |
|---|---|---|---|
| 1 | Retatrutideselected | 38% | 31 |
| 2 | GHK Cu | 33% | 11 |
| 3 | Tirzepatide | 24% | 8 |
Rating trend
Retatrutide rating from this vendor, after each test
Yimei Retatrutide test history
31 tests · 17 pass · 14 fail
| Date | Result | Purity | Dosage | Label |
|---|---|---|---|---|
| 30 Apr 2026 | Pass | 95.3%Identity Pass | -8.5%4.58 mg tested / 5 mg label | Batch RE202631sent by Vendor |
| 19 Apr 2026 | Pass | 94.9%Identity Pass | -8.4%4.58 mg tested / 5 mg label | Batch RE202630sent by Public |
| 27 Mar 2026 | Pass | 96.47%Identity Pass | -3.8%4.81 mg tested / 5 mg label | Batch RE202629sent by Vendor |
| 4 Mar 2026 | Fail | 89.29%Purity Fail | -6.9%4.66 mg tested / 5 mg label | Batch RE202628sent by Vendor |
| 7 Feb 2026 | Pass | 96.23%Identity Pass | -3.8%4.81 mg tested / 5 mg label | Batch RE202627sent by Vendor |
| 9 Jan 2026 | Pass | 96.72%Identity Pass | -5.6%4.72 mg tested / 5 mg label | Batch RE202626sent by Vendor |
| 31 Dec 2025 | Fail | 91.3%Purity Fail | -5%4.75 mg tested / 5 mg label | Batch RE202625sent by Vendor |
| 15 Dec 2025 | Fail | 89.79%Purity Fail | -6.3%4.69 mg tested / 5 mg label | Batch RE202624sent by Public |
| 4 Dec 2025 | Pass | 95.7%Identity Pass | -3.9%4.8 mg tested / 5 mg label | Batch RE202623sent by Vendor |
| 10 Nov 2025 | Pass | 95.1%Identity Pass | -4.3%4.79 mg tested / 5 mg label | Batch RE202622sent by Public |
1-10 of 31